FeaturedGenetics·November 14, 2013·4 min readFDA Approved Immune-Modulating Drug Unexpectedly Benefits Mice With Fatal Mitochondrial DefectRapamycin, a transplant anti-rejection drug, enhances survival and reduces the disease progression in a mouse model of Leigh's syndrome, a new study reports.Read More